Biogen Inc.

BIIB | NASDAQ

Price Alert Chart Builder DCF Calculator

$220.94

+$5.44 (+2.52%)

Sep 21, 2026, 12:02 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	9.81B	9.68B	9.84B	10.17B	10.98B	13.44B
Cost of Revenue	2.9B	2.31B	2.53B	2.28B	2.11B	1.81B
Gross Profit	6.91B	7.37B	7.3B	7.9B	8.87B	11.64B
Operating Income	1.88B	2.49B	2.1B	2.89B	2.79B	4.59B
Interest Income	87.8M	67.6M	276.5M	89.3M	11M	42M
Pretax Income	1.4B	1.91B	1.3B	3.59B	1.78B	5.05B
Net Income	1.29B	1.63B	1.16B	3.05B	1.56B	4B
Selling & General & Admin	2.43B	2.39B	2.5B	2.41B	2.68B	2.52B
Research & Development	1.95B	2.49B	2.7B	2.6B	3.4B	4.53B
Other Expenses	647.7M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	5.04B	4.88B	5.2B	5.01B	6.08B	7.05B
Interest Expense	246M	250.3M	246.9M	246.6M	253.6M	222.5M
Selling & Marketing Expenses	n/a	66.8M	71.4M	54.1M	98.7M	111.8M
Cost & Expenses	7.93B	7.19B	7.74B	7.28B	8.19B	8.85B
Income Tax Expense	108.11M	273.8M	135.3M	632.8M	52.5M	992.3M
Shares Outstanding (Basic)	146.7M	145.7M	144.7M	145.3M	149.1M	160.9M
Shares Outstanding (Diluted)	146.7M	145.9M	145.6M	146M	149.6M	161.3M
EPS (Basic)	8.85	11.20	8.02	20.97	10.44	24.86
EPS (Diluted)	8.83	11.19	7.97	20.87	10.40	24.80
EBITDA	3.1B	3B	2.38B	3.54B	3.92B	5.11B
EBIT	2.17B	2.32B	1.88B	3.02B	3.44B	4.65B
Depreciation & Amortization	935.4M	673.2M	494.8M	518.4M	487.7M	457.2M